Shanghai Haohai Biological Technology Co. Ltd. | Ownership
Companies that own Shanghai Haohai Biological Technology Co. Ltd.
Prime Capital Management Co. Ltd.
6,044,578
15.09%
0
4.03%
12/31/2017
Matthews International Capital Management LLC
4,847,900
12.11%
424,400
0.12%
06/20/2018
Prudence Investment Management (Hong Kong) Ltd.
4,003,400
10%
-3,900
69.81%
08/21/2018
Templeton Investment Counsel LLC
3,634,200
9.07%
0
0.13%
12/31/2017
Norges Bank Investment Management
1,100,800
2.75%
503,001
0%
12/31/2017
Franklin Templeton Investments Corp.
686,300
1.71%
0
0.04%
05/31/2018
ABN AMRO Investment Solutions SA
437,200
1.09%
-220,601
0.04%
06/30/2017
ClearBridge Investments LLC
258,487
0.65%
36,190
0%
06/30/2018
Dimensional Fund Advisors LP
222,100
0.56%
39,400
0%
04/30/2018
Segall Bryant & Hamill LLC
103,200
0.26%
5,000
0.01%
06/30/2018
About Shanghai Haohai Biological Technology Co.
View Profile
| Address |
23/F, WenGuang Plaza
Shanghai Shanghai 200052
China
|
|
Employees
|
- |
| Website |
http://www.3healthcare.com |
| Updated |
07/08/2019 |
| Shanghai Haohai Biological Technology Co., Ltd. engages in the manufacture and sale of biologicals, medical hyaluronate, intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. It operates through the following geographical segments: Mainland China, the United States of America, the United Kingdom, and Other Countries. The company was founded on January 24, 2007 and is headquartered in Shanghai, China. |
